Page last updated: 2024-10-20

uracil and Age-Related Osteoporosis

uracil has been researched along with Age-Related Osteoporosis in 2 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Research Excerpts

ExcerptRelevanceReference
"Trelagliptin is a long-acting inhibitor of DPP-4 used for the management of type 2 diabetes mellitus."5.62Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis. ( Cao, L; Chai, F; Gu, H; Shao, H; Wu, R, 2021)
"Trelagliptin is a long-acting inhibitor of DPP-4 used for the management of type 2 diabetes mellitus."1.62Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis. ( Cao, L; Chai, F; Gu, H; Shao, H; Wu, R, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chau, YP1
Au, PCM1
Li, GHY1
Sing, CW1
Cheng, VKF1
Tan, KCB1
Kung, AWC1
Cheung, CL1
Shao, H1
Wu, R1
Cao, L1
Gu, H1
Chai, F1

Other Studies

2 other studies available for uracil and Age-Related Osteoporosis

ArticleYear
Serum Metabolome of Coffee Consumption and its Association With Bone Mineral Density: The Hong Kong Osteoporosis Study.
    The Journal of clinical endocrinology and metabolism, 2020, 03-01, Volume: 105, Issue:3

    Topics: Absorptiometry, Photon; Alkaloids; Bone Density; Caffeine; Coffee; Diet Surveys; Drinking; Female; F

2020
Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis.
    Bioengineered, 2021, Volume: 12, Issue:1

    Topics: AMP-Activated Protein Kinases; Animals; Cell Differentiation; Cell Line; Core Binding Factor Alpha 1

2021